Vertex Pharmaceuticals (VRTX) Treasury Shares (2010 - 2026)

Vertex Pharmaceuticals has reported Treasury Shares for 17 years, with the latest figure at $700000.0 in Q1 2026.

• For the quarter ending Q1 2026, Treasury Shares fell 22.22% year-over-year to $700000.0; the trailing twelve-month figure through Mar 2026 stood at $700000.0 (down 22.22% YoY), and the FY2025 full-year result was $4.8 million, up 77.78% from the prior year.
• Treasury Shares for Q1 2026 stood at $700000.0, down from $4.8 million in the prior quarter.
• The five-year high for Treasury Shares was $4.8 million in Q4 2025, with the low at $300000.0 in Q1 2024.
• Average Treasury Shares over 5 years is $1.6 million, with a median of $1.1 million recorded in 2024.
• Year-over-year, Treasury Shares plunged 60.1% in 2022 and jumped 200.0% in 2025.
• Tracing VRTX's Treasury Shares over 5 years: stood at $2.9 million in 2022, then plunged by 55.37% to $1.3 million in 2023, then soared by 107.69% to $2.7 million in 2024, then soared by 77.78% to $4.8 million in 2025, then slumped by 85.42% to $700000.0 in 2026.
• The last three Treasury Shares figures came in at $700000.0 (Q1 2026), $4.8 million (Q4 2025), and $2.7 million (Q3 2025), per Business Quant data.

Peer Comparison